Animal Welfare - Environment - Sustainable Development Nexus: Scoping Study

A detailed report on the links between animal welfare, environmental health and global sustainability. Issues discussed include climate change, biodiversity, pollution and waste management, one health, sustainable development and just transitions

Operationalising One Health-One Welfare

The World Health Organisation (WHO) describes One Health as an approach to designing and implementing programmes, policies, legislation and research in which multiple sectors communicate and work together to achieve better public health outcomes. WHO considers the ‘One Health’ approach to be “critical to addressing health threats in the animal, human and environment interface”

Handbook for NGO Success with a Focus on Animal Advocacy

This handbook has been divided into four parts: Animal Protection Issues, Ways of Tackling an Issue, Running an Animal Protection Society and Essential Skills. Part 1 looks at the welfare issues affecting companion animals, farm animals, wildlife, working animals, animals in entertainment and experimental animals, and offers practical strategies to tackle these issues. Part 2 of the handbook considers the various ways of raising the status and improving the treatment of animals. The two main routes, legislation and education, are examined first, followed by practical advice on how to campaign, lobby and use the media to your benefit. Part 3 discusses the main components of running an animal protection society. It outlines the key considerations for establishing a society, as well as how to develop a strategy, manage projects and fundraise. Finally, the importance of support services, libraries and publications is examined. Part 4 gives an overview of many of the professional and personal skills required to run an effective animal protection society: leadership, team building, time management, holding effective meetings, giving presentations, stress management, dealing with compassion fatigue, continuous learning and maintaining motivation.https://www.wellbeingintlstudiesrepository.org/ebooks/1029/thumbnail.jp

Wild Birds: Human & Animal Welfare, Environment, and Global Sustainability

Birds provide many ecosystem services and contribute to human well-being, but their numbers are falling worldwide

Doughnut Economics - Incorporating Animal Welfare

Doughnut Economics is a ground-breaking system developed to change an outdated development paradigm based on endless economic growth, as measured by Gross Domestic Product (GDP), replacing this by a new paradigm that is fit for the 21st century context and challenges, and which meets the needs of all people within the means of the living planet. Doughnut Economics provides an excellent model for charting our post-COVID-19 economics future. We have only one cause for concern. Among its 21 planetary boundaries and societal objectives there is currently no room for animal well-being. COVID-19 has taught us that ignoring how we treat animals is dangerous (as well as unethical). Accordingly, we make the case for the addition of animal welfare/animal issues to Doughnut Economics, as set out in our paper

Aquaculture in Africa: Aquatic Animal Welfare, Impact on the Environment and the Sustainability of the Sector

The African aquaculture sector recorded the fastest growth in the world between 2006-2018, averaging 10% or more, and is expected to partially fill the growing fish supply-demand gap up to 2063. In 2018, there were about 1.2 million aquafarmers across the continent, an increase from 920 thousand in 2014. According to the African Development Bank, expansion of aquaculture in Africa is hampered by the overwhelming predominance of tilapia farming, which relies heavily on the production of fingerlings from a limited number of genetically improved strains that are resistant to the many diseases affecting this species, and on the production of feed that is still largely imported . The Bank cited projections that African aquaculture would grow far more dramatically if it rapidly diversified, rather than remaining dominated by tilapia farming. The review also noted that the sector now generates products not only for direct consumption, but also used in food processing, feed, fuels, cosmetics, nutraceuticals, pharmaceuticals, and a variety of other industrial products

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.

Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data meta-analysis to assess the impact on outcomes of the type, number, and duration of drugs used to treat MDR-TB

Pandemic Influenza A H1N1 2009 Infection versus Vaccination: A Cohort Study Comparing Immune Responses in Pregnancy

Background: With the emergence of H1N1 pandemic (pH1N1) influenza, the CDC recommended that pregnant women be one of five initial target groups to receive the 2009 monovalent H1N1 vaccine, regardless of prior infection with this influenza strain. We sought to compare the immune response of pregnant women to H1N1 infection versus vaccination and to determine the extent of passive immunity conferred to the newborn. Methods/Findings: During the 2009-2010 influenza season, we enrolled a cohort of women who either had confirmed pH1N1 infection during pregnancy, did not have pH1N1 during pregnancy but were vaccinated against pH1N1, or did not have illness or vaccination. Maternal and umbilical cord venous blood samples were collected at delivery. Hemagglutination inhibition assays (HAI) for pH1N1 were performed. Data were analyzed using linear regression analyses. HAIs were performed for matched maternal/cord blood pairs for 16 women with confirmed pH1N1 infection, 14 women vaccinated against pH1N1, and 10 women without infection or vaccination. We found that pH1N1 vaccination and wild-type infection during pregnancy did not differ with respect to (1) HAI titers at delivery, (2) HAI antibody decay slopes over time, and (3) HAI titers in the cord blood. Conclusions: Vaccination against pH1N1 confers a similar HAI antibody response as compared to pH1N1 infection durin

A Double-Blind Randomized Phase I Clinical Trial Targeting ALVAC-HIV Vaccine to Human Dendritic Cells

BACKGROUND: We conducted a novel pilot study comparing different delivery routes of ALVAC-HIV (vCP205), a canarypox vaccine containing HIV gene inserts: env, gag and pol. We explored the concept that direct ex vivo targeting of human dendritic cells (DC) would enhance the immune response compared to either conventional intramuscular or intradermal injections of the vaccine alone. METHODOLOGY/PRINCIPAL FINDINGS: Healthy HIV-1 uninfected volunteers were administered ALVAC-HIV or placebo by intramuscular injection (i.m.), intradermal injection (i.d.) or subcutaneous injection (s.q.) of autologous ex vivo transfected DC at months 0, 1, 3 and 6. All vaccine delivery routes were well tolerated. Binding antibodies were observed to both the ALVAC vector and HIV-1 gp160 proteins. Modest cellular responses were observed in 2/7 individuals in the DC arm and 1/8 in the i.m. arm as determined by IFN-γ ELISPOT. Proliferative responses were most frequent in the DC arm where 4/7 individuals had measurable responses to multiple HIV-1 antigens. Loading DC after maturation resulted in lower gene expression, but overall better responses to both HIV-1 and control antigens, and were associated with better IL-2, TNF-α and IFN-γ production. CONCLUSIONS/SIGNIFICANCE: ALVAC-HIV delivered i.m., i.d. or s.q. with autologous ex vivo transfected DC proved to be safe. The DC arm was most immunogenic. Proliferative immune responses were readily detected with only modest cytotoxic CD8 T cell responses. Loading mature DC with the live viral vaccine induced stronger immune responses than loading immature DC, despite increased transgene expression with the latter approach. Volunteers who received the autologous vaccine loaded mature DC developed a broader and durable immune response compared to those vaccinated by conventional routes. TRIAL REGISTRATION: ClinicalTrials.gov NCT00013572

Hershey Medical Center Technical Workshop Report: Optimizing the design and interpretation of epidemiologic studies for assessing neurodevelopmental effects from in utero chemical exposure

Neurodevelopmental disabilities affect 3-8% of the 4 million babies born each year in the U.S. alone, with known etiology for less than 25% of those disabilities. Numerous investigations have sought to determine the role of environmental exposures in the etiology of a variety of human neurodevelopmental disorders (e.g., learning disabilities, attention deficit-hyperactivity disorder, intellectual disabilities) that are manifested in childhood, adolescence, and young adulthood. A comprehensive critical examination and discussion of the various methodologies commonly used in investigations is needed. The Hershey Medical Center Technical Workshop: Optimizing the design and interpretation of epidemiologic studies for assessing neurodevelopmental effects from in utero chemical exposure provided such a forum for examining these methodologies. The objective of the Workshop was to develop scientific consensus on the key principles and considerations for optimizing the design and interpretation of epidemiologic studies of in utero exposure to environmental chemicals and subsequent neurodevelopmental effects. (The Panel recognized that the nervous system develops post-natally and that critical periods of exposure can span several developmental life stages.) Discussions from the Workshop Panel generated 17 summary points representing key tenets of work in this field. These points stressed the importance of: a well-defined, biologically plausible hypothesis as the foundation of in utero studies for assessing neurodevelopmental outcomes; understanding of the exposure to the environmental chemical(s) of interest, underlying mechanisms of toxicity, and anticipated outcomes; the use of a prospective, longitudinal cohort design that, when possible, runs for periods of 2-5 years, and possibly even longer, in an effort to assess functions at key developmental epochs; measuring potentially confounding variables at regular, fixed time intervals; including measures of specific cognitive and social-emotional domains along with non-cognitive competence in young children, as well as comprehensive measures of health; consistency of research design protocols across studies (i.e., tests, covariates, and analysis styles) in an effort to improve interstudy comparisons; emphasis on design features that minimize introduction of systematic error at all stages of investigation: participant selection, data collection and analysis, and interpretation of results; these would include (but not be limited to) reducing selection bias, using double-blind designs, and avoiding post hoc formulation of hypotheses; a priori data analysis strategies tied to hypotheses and the overall research design, particularly for methods used to characterize and address confounders in any neurodevelopmental study; actual quantitative measurements of exposure, even if indirect, rather than methods based on subject recall; careful examination of standard test batteries to ensure that the battery is tailored to the age group as well as what is known about the specific neurotoxic effects on the developing nervous system; establishment of a system for neurodevelopmental surveillance for tracking the outcomes from in utero exposure across early developmental time periods to determine whether central nervous system injuries may be lying silent until developmentally challenged; ongoing exploration of computerized measures that are culturally and linguistically sensitive, and span the age range from birth into the adolescent years; routine incorporation of narrative in manuscripts concerning the possibility of spurious (i.e., false positive and false negative) test results in all research reportage (this can be facilitated by detailed, transparent reporting of design, covariates, and analyses so that others can attempt to replicate the study); forthright, disciplined, and intellectually honest treatment of the extent to which results of any study are conclusive--that is, how generalizable the results of the study are in terms of the implications for the individual study participants, the community studied, and human health overall; confinement of reporting to the actual research questions, how they were tested, and what the study found, and avoiding, or at least keeping to a minimum, any opinions or speculation concerning public health implications; education of clinicians and policymakers to critically read scientific reports, and to interpret study findings and conclusions appropriately; and recognition by investigators of their ethical duty to report negative as well as positive findings, and the importance of neither minimizing nor exaggerating these findings